Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 15.73
(-0.25%)
CNY 15.73
(-0.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 396.15 Million CNY | -8.4% |
| 2022 | 432.49 Million CNY | 16.5% |
| 2021 | 371.24 Million CNY | 84.94% |
| 2020 | 200.73 Million CNY | -17.56% |
| 2019 | 243.49 Million CNY | 25.41% |
| 2018 | 194.15 Million CNY | 89.36% |
| 2017 | 102.53 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 389.56 Million CNY | 5.08% |
| 2024 Q3 | 383.82 Million CNY | -1.47% |
| 2024 Q1 | 370.73 Million CNY | -6.42% |
| 2023 Q3 | 442.09 Million CNY | -3.06% |
| 2023 FY | 396.15 Million CNY | -8.4% |
| 2023 Q4 | 396.15 Million CNY | -10.39% |
| 2023 Q2 | 456.05 Million CNY | -4.0% |
| 2023 Q1 | 475.04 Million CNY | 9.84% |
| 2022 Q3 | 426.11 Million CNY | 1.38% |
| 2022 Q2 | 420.32 Million CNY | 3.68% |
| 2022 Q1 | 405.41 Million CNY | 9.2% |
| 2022 FY | 432.49 Million CNY | 16.5% |
| 2022 Q4 | 432.49 Million CNY | 1.5% |
| 2021 Q4 | 371.24 Million CNY | 41.74% |
| 2021 Q1 | 216.39 Million CNY | 7.8% |
| 2021 FY | 371.24 Million CNY | 84.94% |
| 2021 Q3 | 261.92 Million CNY | 5.64% |
| 2021 Q2 | 247.93 Million CNY | 14.58% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 200.73 Million CNY | -17.56% |
| 2020 Q4 | 200.73 Million CNY | 0.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q2 | 210.46 Million CNY | 0.0% |
| 2019 FY | 243.49 Million CNY | 25.41% |
| 2019 Q4 | 243.49 Million CNY | 0.0% |
| 2018 FY | 194.15 Million CNY | 89.36% |
| 2017 FY | 102.53 Million CNY | 0.0% |